Att förstå typ 2-inflammation^* kan hjälpa till att belysa varför vissa patienter fortsätter att få exacerbationer. Titta på denna video för att lära dig hur.¹

Prof. Dr. Halvorsen, Prof. Dr. Sinnaeve & Prof. Dr. Martens

In this COPD Research Forum, leading healthcare professionals discuss critical topics such as IL-33, lung function trajectories, and mucus plugging in COPD.

Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare and life-threatening blood disorder characterized by severe deficiency of the enzyme ADAMTS13, leading to the formation of microthrombi in small blood vessels. This condition requires prompt and effective treatment to prevent serious complications.

Caplacizumab is an innovative nanobody^® and cornerstone in the treatment of iTTP.¹ This article delves into real-world data from Belgian hospitals on the use of caplacizumab, highlighting its efficacy, safety, and impact on patient outcomes.²

Symposierapporter Sanofi

Sanofi har med hjälp av AI-verktyg förkortat texterna till sammanfattningar samt översatt dem till svenska.

Systematic early detection of autoimmune Type 1 Diabetes might be a new way to avoid acute and chronic complications of the condition.^1-5 This new approach may play a role as a revolutionary shift, helping to shape the future of Type 1 Diabetes management.²

This infographic summarizes survey data^* about the impact that families across the Nordic countries have felt when being diagnosed with autoimmune Type 1 Diabetes (T1D).

The examination of α-Gal A enzymatic activity can be performed on a Dried Blood Spot (DBS) test. Determination of pronounced α-Gal A deficiency is the definitive method of diagnosis in men.

För levande försvagade vacciner saknas i dagsläget data från systematiska studier, men nedanstående sammanställning syftar till rådgivning kring vaccination med levande vacciner och behandling med Dupilumab utifrån de data som hittills finns att tillgå.